Neron, M.; Guille, A.; Allegre, L.; Colombo, P.-E.; Leaha, C.; Adelaide, J.; Carbuccia, N.; Courtier, F.; Boissiere, F.; Crapez, E.;
et al. Investigation of Molecular Features Involved in Clinical Responses and Survival in Advanced Endometrial Carcinoma Treated by Hormone Therapy. J. Pers. Med. 2022, 12, 655.
https://doi.org/10.3390/jpm12050655
AMA Style
Neron M, Guille A, Allegre L, Colombo P-E, Leaha C, Adelaide J, Carbuccia N, Courtier F, Boissiere F, Crapez E,
et al. Investigation of Molecular Features Involved in Clinical Responses and Survival in Advanced Endometrial Carcinoma Treated by Hormone Therapy. Journal of Personalized Medicine. 2022; 12(5):655.
https://doi.org/10.3390/jpm12050655
Chicago/Turabian Style
Neron, Mathias, Arnaud Guille, Lucie Allegre, Pierre-Emmanuel Colombo, Cristina Leaha, José Adelaide, Nadine Carbuccia, Frédéric Courtier, Florence Boissiere, Evelyne Crapez,
and et al. 2022. "Investigation of Molecular Features Involved in Clinical Responses and Survival in Advanced Endometrial Carcinoma Treated by Hormone Therapy" Journal of Personalized Medicine 12, no. 5: 655.
https://doi.org/10.3390/jpm12050655
APA Style
Neron, M., Guille, A., Allegre, L., Colombo, P.-E., Leaha, C., Adelaide, J., Carbuccia, N., Courtier, F., Boissiere, F., Crapez, E., Fabbro, M., Gouy, S., Mamessier, E., Lambaudie, É., Birnbaum, D., Bertucci, F., & Chaffanet, M.
(2022). Investigation of Molecular Features Involved in Clinical Responses and Survival in Advanced Endometrial Carcinoma Treated by Hormone Therapy. Journal of Personalized Medicine, 12(5), 655.
https://doi.org/10.3390/jpm12050655